Barrett's esophagus: diagnostic challenges and recent developments

Annals of Diagnostic Pathology

Volumn 13, Issue 3, 2009, Pages 212-221

  Maru, Dipen M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Barrett's esophagus; Dysplasia; Intestinal metaplasia; Recent developments; Review

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER GRADING; CYTOLOGY; DISEASE COURSE; DYSPLASIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE METAPLASIA; INTESTINE ULCER; PRIORITY JOURNAL; REVIEW;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; HUMANS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 67349226852     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2009.02.004     Document Type: Review

References (58)

1. Tileston W. Peptic ulcer of the esophagus. J Am Med Sci 132 (1906) 240-265
2. Barrett N.R. Chronic peptic ulcer of the oesophagus and "oesophagitis". Br J Surg 38 (1950-1951) 175-182
3. Allison P.R., and Johnstone A.S. The oesophagus lined with gastric mucous membrane. Thorax 8 (1953) 87-101
4. Barrett N.R. The lower esophagus lined by columnar epithelium. Surgery 41 (1957) 881-894
5. Trier J.S. Morphology of the epithelium of the distal esophagus in patients with midesophageal peptic strictures. Gastroenterology 58 (1970) 444-461
6. Morson B.C., and Belcher J.R. Adenocarcinoma of the oesophagus and ectopic gastric mucosa. Br J Cancer 6 (1952) 127-130
7. Naef A.P., and Savary M. Conservative operations for peptic esophagitis with stenosis in columnar-lined lower esophagus. Ann Thorac Surg 13 (1972) 543-551
8. Cameron A.J., and Lomboy C.T. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103 (1992) 1241-1245
9. Sharma P., McQuaid K., and Dent J. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127 (2004) 310-330
10. Paull A., Trier J.S., Dalton M.B., et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 295 (1976) 476-480
11. Haggitt R.C., Tryzelaar J., Ellis F.H., et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 70 (1978) 1-5
12. Smith R.R.L., Hamilton S.R., Boitnott J.K., et al. The spectrum of carcinoma arising in Barrett's esophagus. Am J Surg Pathol 8 (1984) 563-573
13. Paraf F., Flejou J.F., and Pignon J.P. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 19 (1995) 183-191
14. Harrison R., Perry I., Haddadin W., et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastro 102 (2007) 1154-1161
15. Playford R.J. New British Society of Gastoenterology guidelines for the diagnosis and management of Barrett's oesophagus. Gut 55 4 (2006) 442
16. Wang K.K., and Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103 (2008) 788-797
17. Wright T.A., Gray M.R., Morris A.I., Gilmore I.T., Ellis A., and Smart H.L. Cost effectiveness of detecting Barrett's cancer. Gut 39 (1996) 574-579
18. Spechler S.J., and Goyal R.K. The columnar-lined esophagus, intestinal metaplasia and Normal Barrett. Gastroenterology 110 (1996) 610-621
19. Der R., Tsao-Wei D.D., DeMeester T., et al. Carditis. A manifestation of gastroesophageal reflux disease. Am J Surg Pathol 25 (2001) 245-252
20. Chandrasoma P.T., Lokuhetty D.M., DeMeester T.R., et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 24 (2000) 344-351
21. Chandrasoma P.T., Der R., Ma Y., et al. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 24 (2000) 402-409
22. Kilgore S., Ormsby A.H., Gramlich T.L., et al. The gastric cardia: fact or fiction. Am J Gastroenterology 110 (2000) 614-621
23. Srivastava A., Odze R.D., Lauwers G.Y., et al. Morphologic features are useful in distinguishing Barrett's esophagus from carditis with intestinal metaplasia. Am J Surg Pathol 31 (2007) 1733-1741
24. Odze R.D. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 100 (2005) 1853-1867
25. Spechler S.L. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 117 (1999) 218-228
26. Goldblum J.R. The significance and etiology of intestinal metaplasia of the esophagogastric junction. Ann Diag Pathol 61 (2002) 67-73
27. Jass J.R. Mucin histochemistry of the columnar epithelium of the esophagus. J Clin Pathol 34 (1981) 866-870
28. Haggitt R.C. Barrett's esophagus, dysplasia and adenocarcinoma. Hum Pathol 25 (1994) 982-993
29. Younes M., Ertan A., Ergun G., et al. Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia. Arch Pathol Lab Med 131 (2007) 571-575
30. Ormsby A.H., Goldblum J.R., Rice T.W., et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 30 (1999) 288-294
31. Glickman J.N., Ormsby A.H., Gramlich T., et al. Interinstitutional variability in the interpretation of cytokeratin 7/20 staining patterns in Barrett's esophagus. Gastroenterology 120 (2001) 415A
32. Philips R.W., Frierson H.F., and Moskaluk C.A. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 27 (2003) 1442-1447
33. Glickman J.N., Shahsafaei A., and Odze R.D. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach. Am J Surg Pathol 27 (2003) 1357-1365
34. Menke-Pluymers M.B., Hop W.C., Dees J., et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 72 (1993) 1155-1158
35. Kim S.L., Waring J.P., Spechler S.J., Sampliner R.E., Doos W.G., Krol W.F., and Williford W.O. Diagnostic inconsistencies in Barrett's esophagus, Department of Veterans Affairs Gastroenterology Reflux Study Group. Gastroenterology 107 (1994) 945-949
36. Sharma P., Dent J., Armstrong D., et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C and M criteria. Gastroenterology 131 (2006) 1392-1399
37. Goldblum J.R. Barrett's esophagus and Barrett's related dysplasia. Mod Pathol 16 (2003) 316-324
38. Odze R.D. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 59 (2006) 1029-1038
39. Reid B.J., Blount P.L., and Rabinovitch P.S. Biomarkers in Barrett's esophagus. Gastrointest Endoscopy Clin N Am 13 (2003) 369-397
40. Maley C.C., Galipeau P.C., Li X., et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 64 (2004) 3414-3427
41. Lomo L.C., Bloun P.L., Sanchez C.A., et al. Crypt dysplasia with surface maturation: a clinical pathologic and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol 30 (2006) 423-435
42. Downs-Kelly E., Mendelin J., Bennett A., et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. AM J Gastroenterol 103 (2008) 2333-2340
43. Montgomery E., Goldblum J.R., Greenson J.K., et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 32 (2001) 379-388
44. Weston A.P., Sharma P., Mathur S., et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 99 (2004) 1657-1666
45. Iftikhar S.Y., James P.D., Steele R.J., et al. Length of Barrett's esophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33 (1992) 1155-1158
46. Weston A.P., Banerjee S.K., Sharma P., et al. P53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression. Am J Gastroenterol 96 (2001) 1355-1362
47. Reid B.J., Levine D.S., Longton G., et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high-risk patient subsets. Am J Gastroenterol 95 (2009) 1669-1676
48. Skacel M., Petras R.E., Gramlich T.L., et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications of disease progression. Am J Gastroenterol 35 (2000) 3383-3387
49. Schell T.G., Sontag S.J., Chejfac G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120 (2001) 1607-1619
50. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120 7 (2001) 1630-1639
51. Reid B., Levine J., Longton G., et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high-risk patient subset. Am J Gastroenterol 95 (2000) 1669-1676
52. Fang M., Lew E., Klein M., et al. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric analysis in formalin-fixed tissues. Am J Gastroenterol 99 (2004) 1887-1894
53. Reid B.J., Prevo L.J., Galipeau P.C., et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifiers a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96 (2001) 2839-2848
54. Galipeau P.C., Prevo L.J., Sanchez C.A., et al. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 91 (1999) 2087-2095
55. Sato F., Jin Z., Schulmann K., et al. Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One 3 (2008) e1890
56. Dorer R., and Odze R.D. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol 30 (2006) 871-877
57. Lisovsky M., Falkowski O., and Bhuiya T. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium. Hum Pathol 37 (2006) 1601-1606
58. Parenti A., Leo G., Porzionato A., Zaninotto G., Rosato A., and Ninfo V. Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis. Hum Pathol 37 1 (2006) 16-22